Evaluation of Practice and Awareness of the Safety Profile of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) among Dental Practitioners: A Cross-Sectional Study
DOI:
https://doi.org/10.37376/sjuob.v37i2.7125Keywords:
Benghazi, Dentists, Clinical experience, Level of education, NSAIDs, Safety profileAbstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are the common medications used by dental practitioners to relieve dental pain and control post-operative signs of inflammation. NSAIDs, irrespective of their benefits, have a lot of hazards because of misuse and faulty prescriptions by dentists. The aim of this study is to evaluate the current use of NSAIDs during dental practice and to evaluate the association of the level of education and years of experience of dental practitioners with the awareness of the safety profile of NSAIDs. This observational cross-sectional study was conducted in Benghazi city between August and October 2024. The sample size is composed of 341 dentists. Participants were selected randomly from approximately every dental clinic in Benghazi. The questionnaire is composed of sections including assessment of drug use and drug-precautionary awareness. It is structured with checklist answers and was formulated in English. It is filled by the dentists during a visit to their dental clinics on the basis of an interview. The Statistics Package for Social Science Version 21 (SPSS) software was used for transferring and analysis of data. The results showed that the females accounted for the majority (60.7%). General practitioners represented 67.7% of the participants. About 61.0% of the dentists had clinical experience of less than 10 years. Ibuprofen and Ketoprofen were the most prescribed NSAIDs, 67.2% and 51.6, respectively. More than fifty percent (55.4%) of the participants used to prescribe NSAIDs for less than three days. Postoperative pain and dental pain were the most common clinical indications that NSAIDs were prescribed, 71.3% and 59.5%, respectively. Pregnancy was the most cited to be contraindicated (58.9%). Awareness of avoiding NSAIDs in the case of peptic ulcer patient was associated with years of experience of the dentists (P=0.030). Participants agreed that nausea was the most side effects (45.2%). Awareness of the interaction between NSAIDs and warfarin was associated with the level of education (P=0.006). The outcomes of the study have revealed less comprehension regarding scientific background knowledge of NSAIDs. There was little effect of level of education and years of experience on the awareness of the safety profile of NSAIDs during dental practice. Therefore, a lot of efforts should be focused on improving the knowledge for making proper therapeutic decisions and minimizing the risk of serious adverse effects on the patients who attend dental clinics.
Downloads
References
Jang SM, Jiang R, Grabe D, Pai AB. Assessment of liter-acy and numeracy skills related to non-steroidal anti-inflammatory drug labels. SAGE Open Medicine. 2019 Mar; 7:1-8.
https://doi.org/10.1177/2050312119834119
Puppala N, Reddy GA. Review on Effects of NSAIDs on Different Systems. Asian Journal of Pharmaceutical Re-search and Development. 2020 Feb 15; 8(1):100-9.
https://doi.org/10.22270/ajprd.v8i1.621
Kushwaha V, Agrawal P, Vekaria H, Das A, Shoraisham B, Pathak B. Prostaglandins: An Overview. European Journal of Pharmaceutical and Medical Research. 2024; 11(1):130-139.
Priya SL, RJKGK S. Analgesics In Dentistry-A Review. Indian Journal of Research in Pharmacy and Biotechnol-ogy (IJRPB). 2020 May; 8(3):10-16. doi.org/10.31426/ijrpb
Poveda Roda R, Bagán JV, Jiménez Soriano Y, Gallud Romero L. Use of nonsteroidal antiinflammatory drugs in dental practice: A review. Medicina Oral, Patología Oral y Cirugía Bucal (Internet). 2007 Jan;12(1):10-8.
Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Annals of Pharmacotherapy. 2006 May; 40(5):824-9. doi.org/10.1345/aph.1G428
Farah RI, Khatib AE, Abu Ziyad HJ, Jiad DK, Al Qusous LR, Ababneh AJ, Ajarmeh S. Pattern of use and aware-ness of side-effects of non-steroidal anti-inflammatory drugs in the Jordanian population. Annals of Medicine. 2023 Dec 12; 55(2):2242248. https://doi.org/10.1080/07853890.2023.2242248
Jahnavi K, Reddy PP, Vasudha B, Narender B. Non-steroidal anti-inflammatory drugs: an overview. Journal of Drug Delivery and Therapeutics. 2019 Feb 15; 9(1-s):442- DOI: https://doi.org/10.22270/jddt.v9i1-s.2287
Bushra R, Aslam N. An overview of clinical pharmacol-ogy of Ibuprofen. Oman medical journal. 2010 Jul; 25(3):155. doi: 10.5001/omj.2010.49
Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Archives of internal medicine. 2005 Jan 24; 165(2):189-92.
Der Khatchadourian Z, Moreno-Hay I, de Leeuw R. Nonsteroidal anti-inflammatory drugs and antihyperten-sives: how do they relate?. Oral surgery, oral medicine, oral pathology and oral radiology. 2014 Jun 1; 117(6):697-703. https://doi.org/10.1016/j.oooo.2014.02.028
Sharma A, Sharma K, Neemawat K, Sharma L, Pilania D. Concurrent prescribing: Evaluation of its knowledge among dentists. National Journal of Maxillofacial Sur-gery. 2019 Jan 1; 10(1):73-7. DOI: 10.4103/njms.NJMS_21_18
Ribeiro H, Rodrigues I, Napoleão L, Lira L, Marques D, Veríssimo M, Andrade JP, Dourado M. Non-steroidal an-ti-inflammatory drugs (NSAIDs), pain and aging: Adjust-ing prescription to patient features. Biomedicine & Pharmacotherapy. 2022 Jun 1;150:112958.
Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging and dis-ease. 2018 Feb;9(1):143-150. doi: 10.14336/AD.2017.0306
Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents). 2012 Jun 1;11(1):52-64.
Angiolillo DJ, Weisman SM. Clinical pharmacology and cardiovascular safety of naproxen. American Journal of Cardiovascular Drugs. 2017 Apr;17:97-107.
Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochemical pharmacology. 2020 Oct 1;180:114147. https://doi.org/10.1016/j.bcp.2020.114147
Mullan J, Weston KM, Bonney A, Burns P, Mullan J, Rudd R. Consumer knowledge about over‐the‐counter NSAIDs: they don't know what they don't know. Austral-ian and New Zealand journal of public health. 2017 Apr 1; 41(2):210-4. https://doi.org/10.1111/1753-6405.12589
Krejcie R, Morgan DW. Determining sample size for research activities. Educational and Psychological Meas-urement. 1970; 30:607-10.
www.raosoft.com. Sample size calculation [internt]. 2024. Available from: http://www.raosoft.com/samplesize.
Bradbury F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice. International Journal of Clini-cal Practice. 2004 Oct; 58:27-32. https://doi.org/10.1111/j.1742-1241.2004.027_e.x
Berhouma L, Besbes A, Chokri A, Selmi J. Survey on Tunisian Dentists’ Anti‐Inflammatory Drugs’ Prescrip-tion in Dental Practice. The Scientific World Journal. 2021; 2021(1):6633870.
Halling F, Heymann P, Ziebart T, Neff A. Analgesic prescribing patterns of dental practitioners in Germany. Journal of Cranio-Maxillofacial Surgery. 2018 Oct 1; 46(10):1731-6.
Muthanna FM. Knowledge and Practice of Dentists Re-garding Prescribing of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in Yemen: A Cross-sectional Analysis. Libyan Journal of Medical and Applied Sciences. 2024 Jul 16:1-0.
Yu J, Nie EM, Jiang R, Zhang CY, Li X. Analgesic and Antibiotic Prescription Pattern among Dentists in Guang-zhou: A Cross‐Sectional Study. Pain Research and Man-agement. 2020; 2020(1):6636575.
Al-Otaibi MMD , Alotaibi EGH , Al.Masoud BMA, Al-Wadaei ASS, Almutairi AQK, Alotaibi MBM. Diclo-fenac: An Update on its Mechanism of Action and Safe-ty Profile. Journal of Population Therapeutics and Clini-cal Pharmacology. 2023; 30(2):830-833.
DOI: https://doi.org/10.53555/jptcp.v30i2.4862
Gan TJ. Diclofenac: an update on its mechanism of ac-tion and safety profile. Current medical research and opinion. 2010 Jul 1; 26(7):1715-31.
https://doi.org/10.1185/03007995.2010.486301
Al-juma D. Comparison of the Onset of Diclofenac Po-tassium Sachet (Voltfast) and EntericCoated Diclofenac Potassium (Cataflam) in Treatment of Pain Following Tooth Extraction. Al-Rafidain Dental Journal. 2015 Jun 1; 15(1):369-73. DOI: 10.33899/rden.2015.160874
Ho MK, Chung CH. A prospective, randomised clinical trial comparing oral diclofenac potassium and intramus-cular diclofenac sodium in acute pain relief. Hong Kong Journal of Emergency Medicine. 2004 Apr; 11(2):69-77.
https://doi.org/10.1177/102490790401100202
Sarzi-Puttini P, Atzeni F, Lanata L, Egan CG, Bagnasco M. Safety of ketoprofen compared with ibuprofen and diclofenac: A systematic review and meta-analysis. Trends in Medicine. 2014; 14(14):17-26.
Velásquez GC, Santa Cruz LA, Espinoza MA. Keto-profen is more effective than diclofenac after oral sur-gery when used as a preemptive analgesic: a pilot study. J Oral Facial Pain Headache. 2014 Mar 1; 28(2):153-8.
Sarzi-Puttini P, Atzeni F, Lanata L, Bagnasco M, Colom-bo M, Fischer F, D'Imporzano M. Pain and ketoprofen: what is its role in clinical practice?. Reumatismo. 2010; 62(3):172-88. https://hdl.handle.net/2434/667356
Teoh L, Marino RJ, Stewart K, McCullough MJ. A sur-vey of prescribing practices by general dentists in Aus-tralia. BMC Oral Health. 2019 Dec;19:1-8.
Şermet S, Akgün MA, Şimşek Ş. Analgesic prescription pattern in the management of dental pain among dentists in İstanbul. Marmara Pharmaceutical Journal. 2012 Jan 1;16(1):41-7.
Cooper SA, Desjardins P, Brain P, Paredes-Diaz A, Troullos E, Centofanti R, An B. Longer analgesic effect with naproxen sodium than ibuprofen in post-surgical dental pain: a randomized, double-blind, placebo-controlled, single-dose trial. Current Medical Research and Opinion. 2019 Dec 2; 35(12):2149-58.
https://doi.org/10.1080/03007995.2019.1655257
Stoev SN, Gueоrguiev SR, Madzharov VG, Lebanova HV. Naproxen in pain and inflammation–a review. Int J Pharm Phytopharm Res. 2021 Feb; 11(1):142-8.
Pirlamarla P, Bond RM. FDA labeling of NSAIDs: Re-view of nonsteroidal anti-inflammatory drugs in cardio-vascular disease. Trends in cardiovascular medicine. 2016 Nov 1; 26(8):675-80. https://doi.org/10.1016/j.tcm.2016.04.011
Bruno A, Tacconelli S, Patrignani P. Variability in the response to non‐steroidal anti‐inflammatory drugs: mechanisms and perspectives. Basic & clinical pharma-cology & toxicology. 2014 Jan; 114(1):56-63.
https://doi.org/10.1111/bcpt.12117
Bekker A, Kloepping C, Collingwood S. Meloxicam in the management of post-operative pain: Narrative re-view. Journal of Anaesthesiology Clinical Pharmacology. 2018 Oct 1; 34(4):450-7. DOI: 10.4103/joacp.JOACP_133_18
Orozco-Solís M, García-Ávalos Y, Pichardo-Ramírez C, Tobías-Azúa F, Zapata-Morales JR, Aragon-Martínez OH, Isiordia-Espinoza MA. Single dose of diclofenac or meloxicam for control of pain, facial swelling, and tris-mus in oral surgery. Medicina oral, patologia oral y ciru-gia bucal. 2016 Jan; 21(1):e127. doi: 10.4317/medoral.20925
Ruth M, Hasan CY, Rahardjo R, Rustamadji R. Effects of 15 mg meloxicam administered before odontectomy on pain, facial edema, trismus, and expressions of TNF following odontectomy of impacted mandibular third molar. Journal of Dentomaxillofacial Science. 2020 Aug 1; 5(2):103-9. https://doi.org/10.15562/jdmfs.v5i2.1031
Menshikova I, Zakharova O. Pharmacokinetics of pirox-icam pharmaceutical forms: An experimental study. Cur-rent Trends in Biotechnology and Pharmacy. 2021; 15(2):164-71. DOI : 10.5530/ctbp.2021.2.18
Brustugun J, Notaker N, Paetz LH, Tho I, Bjerknes K. Adjusting the dose in paediatric care: Dispersing four different aspirin tablets and taking a proportion. Europe-an Journal of Hospital Pharmacy. 2021 Mar 1; 28(2):76-82. https://doi.org/10.1136/ejhpharm-2019-001903
Cooper SA, Engel J, Ladov M, Precheur H, Rosenheck A, Rauch D. Analgesic efficacy of an ibuprofen‐codeine combination. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 1982 May 6; 2(3):162-7. https://doi.org/10.1002/j.1875-9114.1982.tb04528.x
Warner TD, Mitchell JA. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. The Lancet. 2008 Jan 19; 371(9608):270-3. DOI: 10.1016/S0140-6736(08)60137-3
Ghosh R, Alajbegovic A, Gomes AV. NSAIDs and car-diovascular diseases: role of reactive oxygen species. Oxidative medicine and cellular longevity. 2015; 2015(1):536962. https://doi.org/10.1155/2015/536962
Monisha M, Elengickal TJ, Ram SKM, Madhu ML, Raghuveeran M, Pillai RRJJoP, et al. Attitude and aware-ness of dentists practicing in Southern India toward non-steroidal anti-inflammatory drugs. 2019;11(Suppl 2):S355-S9.
FDA. FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications [Internet]. 2020. Available from:
Mother to Baby | Fact Sheets. Ibuprofen [Internet]. 2022 [cited 2022 Jul]. Available from: Available from: https://www.ncbi.nlm.nih.gov/books/NBK582759/.
Teichert M, Griens F, Buijs E, Wensing M, De Smet PA. Effectiveness of interventions by community pharma-cists to reduce risk of gastrointestinal side effects in non-selective nonsteroidal anti‐inflammatory drug users. Pharmacoepidemiology and drug safety. 2014 Apr; 23(4):382-9. https://doi.org/10.1002/pds.3587
Pai AB. Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patients. Journal of the American Pharmacists Association. 2015 Jan 1; 55(1):e15-25. https://doi.org/10.1331/JAPhA.2015.15506
Goraya JS, Virdi VS. To the editor: Exacerbation of asthma by ibuprofen in a very young child. Pediatric pulmonology. 2001 Sep; 32(3):262.
Szczeklik A, Nizankowska E, Mastalerz L, Szabo Z. Analgesics and asthma. Am J Ther. 2002 May; 9(3):233-43.
Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs. Therapeutics and clinical risk management. 2015 Jul; 15:1061-75.
Donaldson M, Goodchild JH. Pregnancy, breast-feeding and drugs used in dentistry. The Journal of the American Dental Association. 2012 Aug 1; 143(8):858-71. https://doi.org/10.14219/jada.archive.2012.0290
Rigourd V, de Villepin B, Amirouche A, Bruneau A, Seraissol P, Florent A, Urien S, Magny JF, Serreau R. Ibuprofen concentrations in human mature milk—first data about pharmacokinetics study in breast milk with AOR-10127 “Antalait” study. Therapeutic drug monitor-ing. 2014 Oct 1;36(5):590-6.
Rigourd V, de Villepin B, Seraissol P, Urien S, Delorière E, Nicloux M, Serreau R. Is ketoprofen safe to use when breastfeeding? J of Pharmacol & Clin Res. 2016; 1(1): 555552.
Meaidi A, Mascolo A, Sessa M, Toft-Petersen AP, Skals R, Gerds TA, et al. Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study. bmj. 2023 Sep 6; 382. https://doi.org/10.1136/bmj-2022-074450
Hassan SA, Bhateja S, Arora G, Prathyusha F. Analgesics in dentistry. IP International Journal of Medical Paediat-rics and Oncology 2020; 6(3):90–95.
https://doi.org/10.18231/j.ijmpo.2020.021
Hersh EV, Moore PA. Adverse drug interactions in den-tistry. Periodontology 2000. 2008 Feb 1; 46(1):109-142.
Moore PA, Hersh EV. Principles of pain management in dentistry. The ADA Practical Guide to Substance Use Disorders and Safe Prescribing. 2015 May 5; 5:31.
Webster J. Interactions of NSAIDs with diuretics and β-blockers: mechanisms and clinical implications. Drugs. 1985 Jul; 30(1):32-41. https://doi.org/10.2165/00003495-198530010-00004
Pflugbeil S, Böckl K, Pongratz R, Leitner M, Graninger W, Ortner A. Drug interactions in the treatment of rheu-matoid arthritis and psoriatic arthritis. Rheumatology In-ternational. 2020 Apr; 40:511-21.
https://doi.org/10.1007/s00296-020-04526-3
Kumar S, Thakur PK, Sowmya K, Priyanka S. Evaluation of prescribing pattern of NSAIDs in south Indian teach-ing hospital. Journal of Chitwan Medical College. 2016; 6(4):54-8.
FDA administration. Information for healthcare profes-sionals: Concomitant use of ibuprofen and aspirin. New Information [Internet]. 2006. Available from:
Bakhriansyah M, Souverein PC, de Boer A, Klungel OH. Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study. pharmacoepidemiology and drug safety. 2017 Oct; 26(10):1141-8. https://doi.org/10.1002/pds.4183
Simoneti LF, Weckwerth GM, Dionísio TJ, Torres EA, Zupelari-Gonçalves P, Calvo AM, et al. Efficacy of ke-toprofen with or without omeprazole for pain and in-flammation control after third molar removal. Brazilian dental journal. 2018; 29(2):140-9.

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The Scientific Journal of University of Benghazi

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.